Upgrade to SI Premium - Free Trial

Novartis (NVS) PT Raised to $108 at CFRA

April 23, 2024 1:11 PM
CFRA analyst Wan Nurhayati raised the price target on Novartis (NYSE: NVS) to $108.00 (from $105.00) while maintaining a Hold ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles